This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Prophase Labs, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Joe Abdo: Innovator in Esophageal Cancer Research
Introduction
Joe Abdo is a notable inventor based in Garden City, NY (US). He has made significant contributions to the field of medical research, particularly in understanding esophageal adenocarcinoma. His work focuses on identifying risk factors and developing methods for treatment and prevention of this serious condition.
Latest Patents
Joe Abdo holds a patent for "Systems and methods for Barrett's esophagus pathogenesis and esophageal adenocarcinoma progression revealing markers." This patent outlines methods for assessing the risk of developing esophageal adenocarcinoma in subjects using various marker genes and proteins, including ISG15, LTF, CNDP2, DAD1, SET, UBE2N, S100P, and GPI. The methods also provide strategies for treating and preventing esophageal adenocarcinoma, as well as inhibiting the proliferation and migration of cancer cells.
Career Highlights
Abdo's career is marked by his dedication to advancing medical research and improving patient outcomes. His innovative approaches have the potential to change the landscape of esophageal cancer treatment and prevention.
Collaborations
Joe Abdo collaborates with esteemed colleagues, including Sumeet K Mittal and Devendra K Agrawal, to further enhance the impact of his research.
Conclusion
Joe Abdo's contributions to esophageal cancer research through his innovative patent demonstrate his commitment to improving healthcare outcomes. His work is paving the way for new methods in cancer assessment and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile